Νεα / Δημοσιευσεις
An article published on July 20, 2016 in Gut reports an association between increased intake of marine omega 3 polyunsaturated fatty acids by colorectal cancer patients and a lower risk of dying from the disease. Marine-derived omega 3 fatty acids include EPA and DHA from oily fish or fish oil supplements.
An article published on June 27, 2016 in JAMA Neurology reveals the finding of lower levels of coenzyme Q10 (CoQ10) among men and women with multiple system atrophy (MSA) in comparison with a control group. Multiple system atrophy (MSA) is a progressive neurodegenerative disease characterized by symptoms that affect movement as well as involuntary activity, such as digestion.
According to the American Cancer Society,1 one out of every three women in the United States risks developing some form of cancer over the course of their lives. For men, that number rises to one in two. Since cancer is an age-related disease, the risk of diagnosis increases the longer one lives, making it the second leading cause of death in this country.
The October 11, 2011 issue of the Federation of the American Societies for Experimental Biology (FASEB) Journal reports the finding of Italian and U.S. researchers of an ability for resveratrol to inhibit the growth-promoting effects of estrogen in breast cancer cells.
CLA: Conjugated linoleic acid (CLA) is gaining the attention of a public grown ravenous for new weapons to wield in the never-ending “battle of the bulge.” You may have heard some of the hype, but what is the real story behind this relative newcomer to the weight-loss market?